Results for “”

Entry Author Date Location
GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months 04/06/20 San Francisco
Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment 04/06/20 Boston
Dynacure Adds $55M As RNA-Targeted Muscle Disorder Drug Enters Clinic 04/03/20 Boston
Fate Inks $100M Deal With Janssen for Stem Cell-Derived Cancer Therapies 04/03/20 San Diego
Zentalis Upsizes IPO, Raising $165M for Cancer Drug Clinical Trials 04/03/20 New York
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs 04/03/20 Boston
Flagship Adds $1.1B for New Meds, More AI, & “Health Security” 04/02/20 National
Celularity to Test Natural Killer Cell Therapy for Cancer Against COVID 04/02/20 National
Iteos Therapeutics Adds $125M to Advance Next-Gen Immunotherapies 04/02/20 Boston
Vir Advances Antibodies Against COVID-19, CEO Leads BIO’s Coronavirus Outreach 04/02/20 National
Aspen Neuro Adds $70M to Test Parkinson’s Cell Therapy in the Clinic 04/01/20 San Diego
Pandion Pulls In $80M as Ulcerative Colitis Drug Advances in Clinic 04/01/20 Boston
Aptinyx Moves Ahead With PTSD Therapy Study, Pauses 3 Other Trials 03/31/20 National
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy 03/31/20 Raleigh Durham
Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus 03/31/20 Europe
Biohaven’s Acute Migraine Drug Bests Placebo in Prevention Study 03/30/20 National
Axsome Plans to Try Again After Failure in Treatment-Resistant Depression 03/30/20 New York
San Diego Biotech Entrepreneurs, Innovation Lead to “Maturing” Ecosystem 03/30/20 San Diego
Sanofi Adds mRNA COVID-19 Vaccine Bet Through Translate Bio Alliance 03/27/20 Europe
Equillium Continues Graft-Versus-Host Disease Trial, Pauses 2 Others 03/27/20 San Diego
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Forge Inks Roche Deal For Antibiotic Aimed at Drug-Resistant Infections 03/26/20 San Diego
With $80M, ReCode Looks to Advance RNA Therapies for Lung Diseases 03/26/20 San Francisco
FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch 03/26/20 New York
Oncology Needs Combo Therapies & More Data Analysis, Says Bio-Europe Spring Panel 03/26/20 Boston
Regenacy Pharma Raises $30M for Nerve Function Restoring Treatments 03/25/20 Boston
AstraZeneca Joins RNAi Mix, Pledging $80M to Silence Therapeutics 03/25/20 Europe
Kallyope Gains $112M to Move “Gut-Brain Axis” Programs to the Clinic 03/25/20 New York
CytomX Lands $80M to Kick Off Cancer Drug R&D Pact With Astellas 03/24/20 San Francisco
Page 1 of 1962 next page »